FCLR3 is associated with autoantibodies to IA-2 at diagnosis of Type 1 diabetes

被引：0
|
作者：
Fareed, R. [1 ]
Ye, J. [1 ]
Mortimer, G. [1 ]
Chipper-Keating, S. [1 ]
Chandler, K. [1 ]
Gillespie, K. M. [1 ]
Long, A. E. [1 ]
Williams, A. J. K. [1 ]
机构：
[1] Univ Bristol, Diabet & Metab, Sch Clin Sci, Bristol, Avon, England
来源：
DIABETIC MEDICINE | 2017年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A78
引用
收藏
页码：33 / 33
页数：1
相关论文
共 50 条
  • [31] Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives
    Maclaren, N
    Lan, M
    Coutant, R
    Schatz, D
    Silverstein, J
    Muir, A
    Clare-Salzer, M
    She, JX
    Malone, J
    Crockett, S
    Schwartz, S
    Quattrin, T
    DeSilva, M
    Vander Vegt, P
    Notkins, A
    Krischer, J
    JOURNAL OF AUTOIMMUNITY, 1999, 12 (04) : 279 - 287
  • [32] Cross reactivity between IA-2 and phogrin/IA-2β in binding of autoantibodies in IDDM
    E. C. I. Hatfield
    C. J. Hawkes
    M. A. Payton
    M. R. Christie
    Diabetologia, 1997, 40 : 1327 - 1333
  • [33] IA-2 autoantibody affinity in children at risk for type 1 diabetes
    Krause, Stephanie
    Chmiel, Ruth
    Bonifacio, Ezio
    Scholz, Marlon
    Powell, Michael
    Furmaniak, Jadwiga
    Smith, Bernard Rees
    Ziegler, Anette-G.
    Achenbach, Peter
    CLINICAL IMMUNOLOGY, 2012, 145 (03) : 224 - 229
  • [34] Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus
    Davison, L. J.
    Weenink, S. M.
    Christie, M. R.
    Herrtage, M. E.
    Catchpole, B.
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2008, 126 (1-2) : 83 - 90
  • [35] Autoantibodies and associated T-cell responses to determinants within the 831-860 region of the autoantigen IA-2 in Type 1 diabetes
    Weenink, S. M.
    Lo, J.
    Stephenson, C. R.
    McKinney, P. A.
    Ananieva-Jordanova, R.
    Smith, B. Rees
    Furmaniak, J.
    Tremble, J. M.
    Bodansky, H. J.
    Christie, M. R.
    JOURNAL OF AUTOIMMUNITY, 2009, 33 (02) : 147 - 154
  • [36] Autoantibodies to a 38-kDa glycosylated islet cell membrane-associated antigen in (pre)type 1 diabetes - Association with IA-2 and islet cell autoantibodies
    Winnock, F
    Christie, MR
    Batstra, MR
    Aanstoot, HJ
    Weets, I
    Decochez, K
    Jopart, P
    Nicolaij, D
    Gorus, FK
    DIABETES CARE, 2001, 24 (07) : 1181 - 1186
  • [37] Autoantibodies against IA-2, GAD, and topoisomerase II in type 1 diabetic patients
    Chang, YH
    Shiau, MY
    Tsai, ST
    Lan, MS
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 320 (03) : 802 - 809
  • [38] Recurrence of Type 1 Diabetes After Simultaneous Pancreas-Kidney Transplantation in the Absence of GAD and IA-2 Autoantibodies
    Assalino, M.
    Genevay, M.
    Morel, P.
    Demuylder-Mischler, S.
    Toso, C.
    Berney, T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (02) : 492 - 495
  • [39] GAD, IA-2 and insulin autoantibodies in relation to some risk factors in siblings of Egyptian children with type 1 diabetes
    Assaad-Khalil, SH
    Dyrberg, T
    Michelsen, BK
    El-Azzouni, O
    Abou-Seif, M
    Kamel, F
    Fouad, K
    Abdel-Aty, T
    El-Sheikh, S
    DIABETOLOGIA, 1999, 42 : A93 - A93
  • [40] Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2
    Zavialov, A
    Ankelo, M
    Westerlund-Kaplsson, A
    Knip, M
    Ilonen, J
    Hinkkanen, A
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 246 (1-2) : 91 - 96
12345